SHBG Test · Blood

Your total testosterone or estrogen level can look perfectly normal on a lab report and still be lying to you. The number on the page includes hormones that are locked up, bound to a carrier protein, and unable to do anything. SHBG (sex hormone-binding globulin) is that carrier. It determines how much of your testosterone and estrogen is actually free to enter cells and do its job.

That makes SHBG much more than an accessory measurement. It is a window into your metabolic health, your liver function, and the true hormonal environment your tissues experience every day. When SHBG is too low or too high, the hormones your standard panel reports may not reflect what is happening inside your body.

What SHBG Does in Your Body

SHBG is a protein produced by liver cells and released into the bloodstream. It binds tightly to testosterone and estradiol, keeping roughly 44% of circulating testosterone locked to SHBG and another 50% loosely attached to a different protein called albumin. Only about 2 to 3% of testosterone floats free, and that small free fraction is the biologically active portion, the hormone your muscles, bones, brain, and reproductive organs can actually use.

Because SHBG controls the ratio of bound to free hormone, changes in SHBG shift the amount of active testosterone and estrogen without changing the total. An obese man with low SHBG might have a low total testosterone reading yet normal free testosterone and no symptoms. An older man with rising SHBG might show a normal total testosterone but actually be running low on the free hormone that matters.

SHBG as a Metabolic Sensor

SHBG production in the liver is tightly regulated by a master switch called HNF4-alpha, a gene controller that gets turned down when the liver accumulates fat or when insulin levels are chronically high. This is why SHBG acts as a surprisingly sensitive readout of metabolic health. When your liver is storing excess fat or your cells are becoming resistant to insulin, SHBG drops, sometimes years before your blood sugar or HbA1c crosses into the abnormal range.

Thyroid hormones push SHBG in the opposite direction, increasing its production. Estrogens, especially oral estrogen from contraceptives or hormone replacement therapy, also raise SHBG substantially. Androgens and cortisol-like medications tend to suppress it. These influences mean that interpreting your SHBG level always requires knowing what else is going on in your body.

Type 2 Diabetes Risk

The link between low SHBG and future diabetes is one of the strongest and most consistent findings in the metabolic literature. In a study of about 5,690 adults (mean age 56, mean BMI 30), women in the lowest SHBG quartile were roughly 5 times more likely to develop type 2 diabetes than women in the highest quartile. For men, the risk was about 1.8 times higher. A large portion of this risk, 43% in women and 60% in men, was explained by excess visceral and liver fat.

Earlier research from the Women's Health Study and the Physicians' Health Study found even steeper gradients, with the lowest quartile of SHBG carrying approximately 10 times the diabetes risk compared to the highest quartile in women. Mendelian randomization analyses, which use genetic variants to test whether a relationship is likely causal rather than just correlated, suggest that higher SHBG may play a causal role in protecting against diabetes, though one study found that the causal effect was considerably weaker than the observational association, meaning part of the link may reflect shared underlying metabolic factors rather than a direct effect of SHBG itself.

What this means for you: if your SHBG is drifting downward over time, your metabolic machinery may be shifting toward insulin resistance even if your fasting glucose and HbA1c still look clean. Catching that drift early gives you a head start on reversing it.

Metabolic Syndrome

SHBG tracks closely with metabolic syndrome, a cluster of risk factors that includes abdominal obesity, high triglycerides, high blood sugar, high blood pressure, and low HDL cholesterol. A large meta-analysis pooling individual data from over 22,000 men found that each quartile decrease in SHBG raised the odds of metabolic syndrome by about 73%. The Framingham Heart Study showed that SHBG, but not testosterone itself, independently predicted new cases of metabolic syndrome in men after accounting for BMI and insulin resistance.

The association was strongest for three specific components: high triglycerides, abdominal obesity, and elevated blood sugar. Interestingly, the relationship was most pronounced in men who were not overweight, suggesting that SHBG may be especially informative in leaner individuals who appear metabolically healthy on the surface but carry hidden visceral fat or early insulin resistance.

Heart Disease

A UK Biobank analysis of over 128,000 men and 135,000 women, combined with a meta-analysis totaling more than 350,000 participants, found that higher SHBG was associated with lower coronary heart disease risk in both sexes. Men in the highest SHBG quartile had roughly 19% lower risk than those in the lowest quartile. For women, the reduction was about 14%. Mendelian randomization in the same study suggested the relationship may be causal.

The picture gets more complex when you look at different types of cardiovascular events. In a study of about 210,700 men followed for 9 years, lower SHBG was linked to higher heart attack risk (about 23% higher) but, paradoxically, lower stroke risk and lower heart failure risk. This pattern suggests SHBG's cardiovascular effects depend on which part of the system you are looking at, likely because of its tangled relationship with both metabolic health and sex hormone bioavailability.

Mortality

The relationship between SHBG and death is not straightforward, and the answer depends on sex. In the UK Biobank study of about 149,000 men followed for 11 years, lower SHBG was associated with lower all-cause mortality (about 32% lower risk in the lowest versus highest quintile), lower cardiovascular mortality, and lower cancer mortality. A large individual participant meta-analysis spanning over 255,000 person-years confirmed this pattern in men.

In women, the trend may reverse. A dose-response meta-analysis of 53 publications found that higher SHBG was associated with about 25% higher all-cause mortality in women. This sex-specific paradox likely reflects SHBG's dual nature: in men, lower SHBG often tracks with higher free testosterone (which appears protective), while the same lower SHBG in women may signal metabolic dysfunction without an offsetting hormonal benefit.

Cancer Associations

SHBG's link to cancer risk varies by cancer type and sex, consistent with its role in modulating sex hormone exposure to different tissues.

For hormone-sensitive cancers in women (breast and endometrial), higher SHBG appears protective, likely because it reduces the amount of free estrogen reaching those tissues. For prostate cancer, higher SHBG may lower risk by reducing free testosterone exposure. Liver cancer showed the opposite pattern (higher SHBG linked to higher risk), though this may reflect reverse causation, since liver disease itself raises SHBG.

Reference Ranges

SHBG levels differ significantly by sex and age, and SHBG rises with age in men while following a U-shaped pattern in women (declining until around age 60, then rising). The most widely cited clinical thresholds for low SHBG come from the 2013 to 2016 NHANES survey in the United States.

These thresholds mark the boundary of clinical low SHBG, not an optimal range. There is no consensus on what constitutes an "optimal" SHBG, partly because the ideal level depends on context: higher SHBG appears protective against diabetes and hormone-sensitive cancers, while very high levels can mask low free testosterone. Your lab may report its own reference range, which can differ based on the assay platform used. SHBG assays are generally well standardized across manufacturers, but comparing your results within the same lab over time gives the most reliable trend.

Ethnic and racial differences in SHBG are real and clinically meaningful. Black men tend to have higher SHBG than white men by about 1.5 to 3 nmol/L, while Hispanic men tend to run about 2 nmol/L lower. In postmenopausal women, non-Hispanic white women tend to have lower SHBG than African-American women. These differences persist after adjusting for body composition.

Tracking Your Trend

SHBG is one of the more stable hormone measurements, with a within-person variation of about 7 to 12% from test to test. That is considerably tighter than testosterone (10 to 16%) or luteinizing hormone (24 to 26%). A study following middle-aged men over about 4 years found that SHBG had a concordance correlation of 0.83, meaning your level today is a strong predictor of your level several years from now.

This stability is a strength: it means a downward trend in SHBG over two or three readings is a real signal, not just noise. But it also means that population-based reference ranges are less useful than your own personal baseline. Research shows that SHBG has a low "index of individuality" (about 0.49), which is a statistical way of saying that the normal range for all people is too wide to tell you much about what is normal for you specifically. Get a baseline, retest in 3 to 6 months if you are making lifestyle changes, and then at least annually. Two to three measurements before making clinical decisions is the standard recommendation.

When Results Can Be Misleading

SHBG does not have significant circadian variation, so timing of the blood draw matters less than it does for testosterone. That said, several factors can shift your reading in ways that do not reflect your true metabolic status.

• Acute illness or surgery: Critical illness can suppress testosterone levels by 40 to 60% within 24 hours, though SHBG itself typically stays stable. Wait until you have fully recovered before testing to avoid misleading hormone calculations.
• Intense exercise within 2 hours of the draw: Moderate to high-intensity exercise transiently raises both testosterone (14 to 39%) and SHBG (14 to 19%) immediately afterward, mostly due to fluid shifts concentrating the blood. These levels return to normal within 1 to 2 hours. Avoid strenuous exercise on the morning of your test.
• Oral contraceptives and estrogen therapy: These can double SHBG levels or more, making any testosterone panel drawn while on these medications difficult to interpret in the usual metabolic context. This is an expected pharmacological effect, not a disease signal.
• Statins: These medications lower SHBG by about 3 to 4 nmol/L. This is a modest shift but could push a borderline reading below a threshold. If you are on a statin, factor this into your interpretation.

Enzyme-inducing anticonvulsants (such as carbamazepine, phenytoin, and phenobarbital) raise SHBG substantially. Glucocorticoids push it down. If you are on any of these medications, your SHBG reflects the drug's effect on liver protein production, not necessarily your underlying metabolic health.